Cargando…

Correction: Residual Axillary Burden After Neoadjuvant Chemotherapy (NACT) in Early Breast Cancer in Patients with a priori Clinically Occult Nodal Metastases – a transSENTINA Analysis

Detalles Bibliográficos
Autores principales:	Kolberg, Hans-Christian, Kühn, Thorsten, Krajewska, Maja, Bauerfeind, Ingo, Fehm, Tanja N., Fleige, Barbara, Helms, Gisela, Lebeau, Annette, Stäbler, Annette, Schmatloch, Sabine, Hauschild, Maik, Schwentner, Lukas, Schrenk, Peter, Loibl, Sibylle, Untch, Michael, Kolberg-Liedtke, Cornelia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2020
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738234/ https://www.ncbi.nlm.nih.gov/pubmed/33335331 http://dx.doi.org/10.1055/a-1336-7155

Ejemplares similares

Residual Axillary Burden After Neoadjuvant Chemotherapy (NACT) in Early Breast Cancer in Patients with a priori Clinically Occult Nodal Metastases – a transSENTINA Analysis
por: Kolberg, Hans-Christian, et al.
Publicado: (2020)

De miasmas, humores y sentinas : La revolución médica y sanitaria del control de Veracruz (1750-1870) /
por: Strobel del Moral, Héctor Manuel
Publicado: (2015)

The NACT Training Package
por: Scarpello, John H. B.
Publicado: (1991)

L-Arginine and Cardioactive Arginine Derivatives as Substrates and Inhibitors of Human and Mouse NaCT/Nact
por: Surrer, Daniela B., et al.
Publicado: (2022)

NACT+IMRT versus NACT+IMRT+CCRT in locoregionally advanced NPC patients: a retrospective study
por: Chen, Xialin, et al.
Publicado: (2019)

Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) – Recommendations for Daily Routine Practice
por: Schneeweiss, Andreas, et al.
Publicado: (2019)

Structure and inhibition mechanism of the human citrate transporter NaCT
por: Sauer, David B., et al.
Publicado: (2021)

Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab – a translational project in the neoadjuvant GeparQuinto trial
por: Witzel, I, et al.
Publicado: (2012)

The Role of GOLPH3L in the Prognosis and NACT response in Cervical Cancer
por: Feng, Yanling, et al.
Publicado: (2017)

Correlation of clinicopathological outcomes with changes in IHC4 status after NACT in locally advanced breast cancers: do pre-NACT ER/PR status act as better prognosticators?
por: Chatterjee, Sanjoy, et al.
Publicado: (2015)

Treatment of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: German Expert Opinions on the 17th International St. Gallen Consensus Conference
por: Untch, Michael, et al.
Publicado: (2021)

A Priori Reasoning as to Pathogeny
Publicado: (1917)

Expression of thioredoxin 1 and peroxiredoxins in squamous cervical carcinoma and its predictive role in NACT
por: Zhu, Haiyan, et al.
Publicado: (2019)

Oncologic safety of breast conservation following NACT in women with locally advanced breast cancer
por: Agrawal, Sanjit Kumar, et al.
Publicado: (2023)

Update Breast Cancer 2021 Part 3 – Current Developments in the Treatment of Early Breast Cancer: Review and Assessment of Specialised Treatment Scenarios by an International Expert Panel
por: Fehm, Tanja N., et al.
Publicado: (2021)

Current Medical Treatment of Patients with Non-Colorectal Liver Metastases: Primary Tumor Breast Cancer
por: Liedtke, Cornelia, et al.
Publicado: (2015)

The A Priori Traveling Repairman Problem
por: van Ee, Martijn, et al.
Publicado: (2017)

Lo a priori constitutivo : historia y prospectiva /
por: Pelaéz Cedrés, Álvaro J., 1968-
Publicado: (2008)

Model‐Based Assessment of Plasma Citrate Flux Into the Liver: Implications for NaCT as a Therapeutic Target
por: Li, Z, et al.
Publicado: (2016)

Benchmarking tools for a priori identifiability analysis
por: Rey Barreiro, Xabier, et al.
Publicado: (2023)

Localization on a-priori information of plane extraction
por: Ji, Junjie, et al.
Publicado: (2023)

Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists on the 16th St. Gallen International Breast Cancer Conference (Vienna 2019)
por: Untch, Michael, et al.
Publicado: (2019)

Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5)
por: Huard, Kim, et al.
Publicado: (2015)

NaCT/SLC13A5 facilitates citrate import and metabolism under nutrient-limited conditions
por: Kumar, Avi, et al.
Publicado: (2021)

“This house believes that: Sentinel node biopsy alone is better than TAD after NACT for cN+ patients”
por: Galimberti, Viviana, et al.
Publicado: (2022)

Analysis of naturally occurring mutations in the human uptake transporter NaCT important for bone and brain development and energy metabolism
por: Selch, Stefan, et al.
Publicado: (2018)

The Hepatic Plasma Membrane Citrate Transporter NaCT (SLC13A5) as a Molecular Target for Metformin
por: Kopel, Jonathan, et al.
Publicado: (2020)

LEYES FUNDAMENTALES, A PRIORI RELATIVIZADOS Y GÉNEROS
por: Falguera, José Luis
Publicado: (2013)

Regression Analysis Under A Priori Parameter Restrictions
por: Knopov, Pavel S, et al.
Publicado: (2012)

Update Breast Cancer 2021 Part 4 – Prevention and Early Stages
por: Thomssen, Christoph, et al.
Publicado: (2022)

Update Breast Cancer 2021 Part 5 – Advanced Breast Cancer
por: Lüftner, Diana, et al.
Publicado: (2022)

Correction: Update Breast Cancer 2021 Part 5 – Advanced Breast Cancer
por: Lüftner, Diana, et al.
Publicado: (2022)

Use of Taxanes in Metastatic HER2-negative Breast Cancer – a Status Report
por: Gluz, Oleg, et al.
Publicado: (2020)

The sodium-dependent di- and tricarboxylate transporter, NaCT, is not responsible for the uptake of D-, L-2-hydroxyglutarate and 3-hydroxyglutarate into neurons
por: Brauburger, Katja, et al.
Publicado: (2011)

Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands
por: Miquel-Cases, Anna, et al.
Publicado: (2016)

Update Breast Cancer 2022 Part 4 – Advanced-Stage Breast Cancer
por: Aktas, Bahriye, et al.
Publicado: (2022)

Update Breast Cancer 2022 Part 3 – Early-Stage Breast Cancer
por: Fehm, Tanja N., et al.
Publicado: (2022)

Update Breast Cancer 2022 Part 5 – Early Stage Breast Cancer
por: Fehm, Tanja N., et al.
Publicado: (2023)

Update Breast Cancer 2022 Part 6 – Advanced-Stage Breast Cancer
por: Lüftner, Diana, et al.
Publicado: (2023)

Explicit "a priori" inequalities with applications to boundary value problems
por: Sigillito, V G
Publicado: (1977)

Cannot write session to /tmp/vufind_sessions/sess_vbj8p3ddruutedqi4kiga74e3n